You are here

NUBAD, LLC

Company Information
Address
900 B W Faris Rd
Greenville, SC 29605-4255
United States


https://nubadllc.com

Information

DUNS: 831389122

# of Employees: 6


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Delivery of chemically modified PNA oligomers

    Amount: $299,999.00

    PROJECT SUMMARYRNA is a validated target for drug design, both as therapeutic and as a target. Targeting specific RNA, such as rRNA which are involved in proliferation and survival of bacteria is a pr ...

    STTRPhase I2020Department of Health and Human Services National Institutes of Health
  2. A biophysical assay for RNA based resistance

    Amount: $288,889.00

    PROJECT SUMMARY The world is rapidly heading towards a pre-1940andapos;s scenario when it comes to fighting infectious disease. Antimicrobial resistance is a growing problem on a global scale, greatly ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  3. Aminoglycosides with reduced ototoxicity via miRNA targeting

    Amount: $754,902.00

    PROJECT SUMMARYAminoglycosides are one of the cheapest and well-known antibiotics in clinical use for over 70 years, but one of the major limitations in their use is their ototoxicity. We are developi ...

    STTRPhase I2019Department of Health and Human Services National Institutes of Health
  4. Nucleobase aminosugars with reduced ototoxicity

    Amount: $670,352.00

    PROJECT SUMMARYAminoglycosides are one of the cheapest and well known antibiotics in clinical use for overyearsbut one of the major limitations in their use is their ototoxicityWe are developing fast ...

    STTRPhase I2018Department of Health and Human Services National Institutes of Health
  5. Aminoglycosides with reduced ototoxicity

    Amount: $600,000.00

    PROJECT SUMMARY Aminoglycosides are one of the cheapest and well known antibiotics in clinical use for over years but one of the major limitations in their use is their ototoxicity We are develo ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
  6. Screening the Ribosome for New Target Sites

    Amount: $650,000.00

    DESCRIPTION provided by applicant Nucleic acids are avenues for drug design both as therapeutics and as targets Here we propose to establish new methods for identifying antibiotic ribosome target ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
  7. Development of Aminoglycoside-Nucleic Acid Conjugates for Inactivation of an Antibiotic Resistance-Conferring Aminoglycoside Sensing Riboswitch

    Amount: $464,380.00

    DESCRIPTION provided by applicant The world is rapidly heading towards a pre andapos s scenario when it comes to fighting infectious disease Antimicrobial resistance is a growing problem on a ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  8. A Rapid assay for RNA targeted drugs: Instrumentation Supplement

    Amount: $1,430,141.00

    DESCRIPTION provided by applicant Some of the most significant therapies that treat disease target nucleic acids Drugs that target nucleic acid include cancer drugs antibiotics and antivirals C ...

    STTRPhase II2014Department of Health and Human Services National Institutes of Health
  9. Development of Peptide Antibiotic Nucleic Acids

    Amount: $595,355.00

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and p ...

    STTRPhase I2014Department of Health and Human Services National Institutes of Health
  10. Targeting RNA conformation for drug development

    Amount: $294,583.00

    DESCRIPTION (provided by applicant): One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and pr ...

    STTRPhase I2012Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government